CTI BIOPHARMA CORP reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Seattle, WA
SEC filing record 1 source field available
Fiscal year end
31 December
CTI BIOPHARMA CORP has filed 2,393 SEC EDGAR filings since 27 Jun 1996

SEC filing history

Showing 51-75 of 402 matching filings.

Per page
25
Current page
3
8-K File 000-28386

8-K

Filing date
03 Jan 2019
Reporting date
03 Jan 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-28386

8-K

Filing date
28 Dec 2018
Reporting date
28 Dec 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-28386

8-K

Filing date
18 Dec 2018
Reporting date
18 Dec 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-28386

8-K

Filing date
13 Dec 2018
Reporting date
13 Dec 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-28386

8-K

Filing date
26 Nov 2018
Reporting date
26 Nov 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-28386

8-K

Filing date
01 Nov 2018
Reporting date
01 Nov 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-28386

8-K

Filing date
01 Nov 2018
Reporting date
01 Nov 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-28386

8-K

Filing date
24 Sep 2018
Reporting date
18 Sep 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-28386

8-K

Filing date
06 Sep 2018
Reporting date
04 Sep 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-28386

8-K

Filing date
15 Aug 2018
Reporting date
14 Aug 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-28386

8-K

Filing date
03 Aug 2018
Reporting date
02 Aug 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-28386

8-K

Filing date
02 Aug 2018
Reporting date
02 Aug 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-28386

8-K

Filing date
19 Jul 2018
Reporting date
13 Jul 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-28386

8-K

Filing date
25 May 2018
Reporting date
24 May 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-28386

8-K

Filing date
21 May 2018
Reporting date
21 May 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-28386

8-K

Filing date
03 May 2018
Reporting date
03 May 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-28386

8-K

Filing date
23 Mar 2018
Reporting date
23 Mar 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-28386

8-K

Filing date
07 Mar 2018
Reporting date
07 Mar 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-28386

8-K

Filing date
28 Feb 2018
Reporting date
28 Feb 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-28386

8-K

Filing date
12 Feb 2018
Reporting date
12 Feb 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-28386

8-K

Filing date
31 Jan 2018
Reporting date
31 Jan 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-28386

8-K

Filing date
25 Jan 2018
Reporting date
25 Jan 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-28386

8-K

Filing date
24 Jan 2018
Reporting date
24 Jan 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-28386

8-K

Filing date
18 Jan 2018
Reporting date
17 Jan 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-28386

8-K

Filing date
05 Jan 2018
Reporting date
05 Jan 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .